SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)
$16.03 -0.17 (-1.0494%)
Analysed SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) News Sources
Akeso Announces Opening of Global Phase II Study of Ivonescimab in First-Line Clear Cell Renal Cell Carcinoma, Including Combination with Cadonilimab
19-10-2026
yahoo.com
AstraZeneca CEO Pascal Soriot on Summit ivonescimab combos
06-10-2026
qz.com
Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now
07-10-2026
beincrypto.com
Summit Therapeutics Announces Opening of Global Phase II Study of Ivonescimab-Based Regimens in Advanced Clear Cell Renal Cell Carcinoma
19-10-2026
yahoo.com
Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer
21-10-2026
yahoo.com
Summit Therapeutics and Lunit Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
23-10-2026
yahoo.com
Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
24-10-2026
yahoo.com
Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 Study Conducted by Akeso in China
25-10-2026
yahoo.com
Lunit and Summit to evaluate pathology platform for tumour analysis
26-10-2026
pharmaceutical-technology.com
Summit Therapeutics (SMMT) Could Be 46% Undervalued On New Cancer Trials And AI Deal
30-10-2026
yahoo.com
What is the current price of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The current price of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is $16.03.
SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) since the previous trading day is $-0.17.
SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) since the previous trading day is -1.0494%.
What is the most recent average sentiment score for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The most recent average sentiment score for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The most recent sentiment for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is .
SEC-8K** Filing Available For SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.